Fund moves
12 tracked managers disclosed the same change for Q4 2025. From a 13F filed Mar 16, 2026 covering holdings at Dec 31, 2025 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Signed Apr 3, 2026 · Updated Apr 3, 2026
The Department of Veterans Affairs has committed $36K to Madrigal Pharmaceuticals so far. It runs until Apr 7, 2026.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
$35,623
Actual federal dollars obligated to date on this award
$35,623
A maximum, not earned revenue
$65K across 2 awards
Obligations to date on awards newly signed in the last 12 months, mapped to this company
100% from the largest awarding agency
Share of T12M mapped obligations
Largest mapped award on record
Within the awards OQRO has ingested
Not available
No annual revenue figure from the company's SEC filings yet
exact identifier
Exact identifier > verified alias > manual override
Fund moves
12 tracked managers disclosed the same change for Q4 2025. From a 13F filed Mar 16, 2026 covering holdings at Dec 31, 2025 — a quarter-end snapshot, not a live trade.
Fund moves
9 tracked managers disclosed the same change for Q4 2025. From a 13F filed Feb 27, 2026 covering holdings at Dec 31, 2025 — a quarter-end snapshot, not a live trade.
Fund moves
9 tracked managers disclosed the same change for Q4 2025. From a 13F filed Feb 17, 2026 covering holdings at Dec 31, 2025 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.